Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Rutgers Biologics Team to Support Study on the Genetics of Addiction

7/7/2015

0 Comments

 
New Brunswick, NJ - Rutgers University Cell and DNA Repository (RUCDR) Infinite Biologics , BioRealm, LLC, and – Affymetrix, Inc. announced a broad strategic alliance.  This alliance will leverage BioRealm's SmokeScreen® platform to genotype the National Institute on Drug Abuse (NIDA) biorepository of more than 50,000 samples, collected from human subjects studied in NIDA-funded research.  NIDA preserves these samples in a biorepository at RUCDR Infinite Biologics, on the campus of Rutgers University. 
The biorepository is maintained by RUCDR Infinite Biologics and in part through collaboration with the BioProcessing Solutions Alliance which was created by RUDCR Infinite Biologics and BioStorage Technologies, the global leader in comprehensive sample management.

Once the genetic information contained in these samples is made available to researchers, it will be extremely valuable for studying the link between genetic variations and addiction. Detailed genetic information might, for example, be used by researchers exploring how genetics influences patients’ individual responses to treatment approaches.

To date, the genetic information contained in these samples has been focused on specific targets and not collectively analyzed.  This strategic alliance makes it possible, for the first time ever, to cost-efficiently analyze this valuable information. The genetic information will be obtained by using BioRealm’s SmokeScreen® array, developed in conjunction with NIDA’s Genetics Consortium and Affymetrix. SmokeScreen® array is a genome-wide array with research-driven focus on more than 1,000 addiction-related genes.

BioRealm’s Co-Founder Dr. James Baurley remarked, “We are extremely honored to have the help and support of Affymetrix and RUCDR. Our SmokeScreen® technology provides a suite of genomic research tools to scientists working on addiction – one of the biggest public health threats. Because of our partners’ confidence in our technology, it will be made available to scientific teams around the world who are working on these critical health issues.”

RUCDR Infinite Biologics’ Chief Operating Officer and Director of Technology Development Dr. Andrew Brooks said, “Because of the SmokeScreen® array, we have the ability to reveal genetic information previously hidden in NIDA's samples. We have great confidence in SmokeScreen® ‒ it is a validated platform that will become a crucial tool in advancing addiction research and moving the field towards personalized treatment.”

According to Dr. Frank R. Witney, President and Chief Executive Officer of Affymetrix, “We are excited to be part of BioRealm’s vision of improving human health by providing insight into the genetics of tobacco-related illness. It was a pleasure to work with BioRealm’s team of dedicated scientists to co-develop this cutting-edge technology.”


About BioRealm LLC

BioRealm, a life sciences company headquartered in Monument, Colorado, uses novel technology to provide end-to-end services for researchers and product development teams, including study design, data management, and data analysis. BioRealm’s cutting-edge products and technologies support the research process, from hypothesis to conclusion. BioRealm’s SmokeScreen® platform provides researchers with unique insight into the genetics of addiction, smoking behavior, and treatment approaches. Read more at http://biorealmresearch.com/.

About RUCDR Infinite Biologics              
 
RUCDR Infinite Biologics offers a complete and integrated        selection of biological sample processing, analysis and biorepository services to government agencies, academic institutions, foundations, and biotechnology and pharmaceutical companies within the global scientific community. RUCDR provides DNA, RNA, and cell lines with clinical data to hundreds of research laboratories for studies on mental health and developmental disorders, drug and alcohol abuse, diabetes and digestive, liver, and kidney diseases. A unit of Rutgers University’s Human Genetics Institute of New Jersey, RUCDR is the world’s largest university-based biorepository. In 2012, a Bioprocessing Solutions Alliance was created between RUCDR and BioStorage Technologies to provide research companies and organizations with a state-of-the-art scientific and technology infrastructure for the delivery of advanced sample bioprocessing and biobanking solutions. Read more at www.rucdr.org.

About Affymetrix

Affymetrix technologies enable multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of bench-top research into clinical and routine use for human health and wellness. Affymetrix provides leadership and support, partnering with customers in pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and non-profit research institutes in their quest to use biology for a better world. More than 2,300 microarray systems have been shipped around the world and more than 94,000 peer-reviewed papers have been published citing Affymetrix technologies. Affymetrix is headquartered in Santa Clara, California, and has manufacturing facilities in Cleveland, Ohio, San Diego, Vienna, and Singapore. Affymetrix has about 1,100 employees worldwide and maintains sales and distribution operations across Europe, Asia, and Latin America. For more information about Affymetrix, please visit www.affymetrix.com.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619